The future of medicine is health care that is customized to fit the individual patient. In its early stages now, personalized, or precision, medicine uses tests of biomarkers and other genetic information to prevent, diagnose and treat diseases.

This conference will explore key issues in this evolving field, including the revolutionary CRISPR gene-editing technology featuring the CEO of Caribou Biosciences. Other featured speakers will discuss how personalized medicine and other innovations are improving the lives of cancer patients, precision medicine and clinical trials, as well as funding opportunities for innovators and the kinds of projects venture capitalists are interested in financing.

See more information here.